We are a passionate team of advocates who are leading a digital health revolution.

Strategic Advisors

Rt Hon Alan Milburn

Rt Hon Alan Milburn served in the United Kingdom government as a Member of Parliament and a Cabinet minister under Prime Minister Blair where he held the roles of Secretary of State for Health, Chief Secretary to the Treasury, and Chancellor of the Duchy of Lancaster. While overseeing the National Health Service (NHS) he worked to reduce waiting times, modernize healthcare delivery, and improve the performance of the health system. Mr. Milburn has subsequently been appointed by Prime Minister Cameron as Chair of the Social Mobility and Child Poverty Commission.

Today, Mr. Alan Milburn serves as the Chairman of the European Advisory Board of Bridgepoint Advisers Limited. He is also Chair of the Global Advisors for Mars Incorporated and is Chair of PwC's UK Health Industries Oversight Board. He is chairman of iWantGreatCare Ltd and serves as Non-Executive Director of Diaverum AB.

Yves Nordmann, MD

Yves Nordmann, Founder Emeritus of WellDoc, was born in Switzerland and completed Medical School from 1993 to 1999 in Basel, Paris and New York. He specialized in pediatrics and served at the University of Maryland School of Medicine's Division of Pediatric Endocrinology, where he was awarded a Fellowship-Grant from the Swiss National Science Foundation.

Dr. Nordmann founded WellDoc together with Dr. Suzanne Clough and Ryan Sysko in 2005. Dr. Nordmann is a board certified pediatrician in Switzerland and holds the ECFMG Certification of the United States Medical Licensing Examination. Since June 2006 he owns a private pediatric practice in Zurich and since 2007 he acts as Chief Medical Director for E-Medicus, a Switzerland based company developing EMR and e-health solutions for private practices and clinics.

Dr. Nordmann is a member of the FMH Swiss Medical Association and of the Swiss Society of Pediatrics.

Christopher T. Rogers, J.D.

Christopher T. Rogers, J.D. was the co-founder of Nextel Communications (sold to Sprint for $35 billion) and several of its predecessor companies. Mr. Rogers brings 30 years of mobile industry experience as a founder, advisor and operator. Most recently, Rogers served as Senior Vice President, Corporate Development and Spectrum, of Sprint where he evaluated and executed strategic initiatives, including mergers, acquisitions, divestitures, equity investments and joint ventures within the mobile communication and e-commerce sectors. He also was responsible for management and oversight of wireless spectrum licenses and Sprint's investment portfolio of emerging technology start-ups. Prior to the 2005 Sprint Nextel merger, Rogers was Co-Founder and Senior Vice President of Nextel Communications, Inc. Before Nextel Communications, Rogers was co-Founder of FleetCall Communications, the predecessor to Nextel Communications, and Founder and Chairman of Dispatch Communications, which was sold to Fleet Call/Nextel in 1993. Rogers served as a director on multiple public and private company boards and as a director for several Washington, D.C.-based philanthropic organizations.

He received his JD from the Columbus School of Law at Catholic University and his bachelor's degree from Tufts University.

Daniel Rosenberg

Daniel Rosenberg is one of the founders of the user experience field, having contributed to several of the first books in the field. He has over 3 decades of software designer experience and has invented many commonly used UX concepts and patterns. He is also known as a global design leader having served as the design SVP for both Oracle and SAP for a combined duration of 18 years.

Dan is an adjunct professor at San Jose State University and consults through rCDOUX.com. His clients include both startups and publically held companies in the medical, consumer, big data and enterprise software areas. He has been advising with WellDoc for approximately 2 years.

Dan is a forum editor and blogger for ACM interactions magazine and is also a frequently invited keynote speaker at user experience conferences around the world.

Michael Stocker, MD

Michael Stocker, MD serves as the Chairman of the Board of the New York City Health and Hospitals Corporation (HHC), the largest municipal hospital and health care system in the country, serving 1.3 million New Yorkers annually. Prior to this role, he served as executive vice president of WellPoint, chief executive officer of Empire Blue Cross and Blue Shield, president of Cigna Health Plans, and general manager of U.S. Healthcare. He has also held many board positions including being a Board Member at FAIR Health and Coventry Health Care, which was recently acquired by Aetna. Dr. Stocker also frequently volunteers his expertise in healthcare administration across public and private organizations. Presently he is a board member of the Arthur Ashe Institute for Urban Health as well as the United Hospital Fund and he previously served as a member of the New Jersey Governor's Health Care Cost Reduction Advisory Committee and the National Committee for Quality Assurance (NCQA).

Earlier in his career, Dr. Stocker was a practicing physician at Cook County Hospital in Chicago and a medical director at Anchor HMO at Rush Presbyterian St. Luke's Medical Center. Dr. Stocker was educated at the University of Notre Dame and received his MD from the Medical College of Wisconsin. He received his postgraduate training at the Mayo Clinic and the University of California and is board certified in Internal Medicine and Family Practice. Dr. Stocker also holds a Master's degree in Public Health from the University of Michigan and he served his country in the United States Army.

H. Thomas Watkins

H. Thomas Watkins served as the President and Chief Executive Officer of Human Genome Sciences, Inc. and as a member of its Board of Directors from 2005 until August 2012, when Human Genome Sciences, Inc. was acquired by GlaxoSmithKline. Prior to his tenure at Human Genome Sciences, Inc., Mr. Watkins served as President of TAP Pharmaceutical Products, Inc. Mr. Watkins previously held a series of executive positions over the course of nearly twenty years with Abbott Laboratories. Mr. Watkins also serves on the Board of Directors of the Biotechnology Industry Organization (BIO), and has served as Chair of the BIO Board of Directors. Previously he was appointed by Governor O'Malley to Chair the Life Sciences Advisory Board for the state of Maryland. He holds a B.B.A. from the College of William and Mary and an M.B.A from the University of Chicago Graduate School of Business.